| Breakdown | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.63B | 2.89B | 2.35B | 1.18B | 851.70M |
| Gross Profit | 2.71B | 1.29B | 1.69B | 862.30M | 825.30M |
| EBITDA | 1.21B | 865.80M | 705.40M | 284.30M | 106.60M |
| Net Income | 308.20M | 218.00M | 128.00M | 91.60M | 56.50M |
Balance Sheet | |||||
| Total Assets | 34.68B | 24.31B | 17.61B | 15.74B | 5.26B |
| Cash, Cash Equivalents and Short-Term Investments | 13.46B | 5.21B | 4.73B | 3.22B | 758.30M |
| Total Debt | 10.17B | 6.14B | 5.39B | 5.73B | 1.29B |
| Total Liabilities | 33.41B | 23.34B | 16.84B | 15.07B | 4.79B |
| Stockholders Equity | 1.26B | 976.90M | 775.90M | 677.70M | 477.70M |
Cash Flow | |||||
| Free Cash Flow | 654.40M | 1.14B | 722.90M | 216.20M | 463.50M |
| Operating Cash Flow | 667.50M | 1.16B | 735.00M | 225.60M | 470.80M |
| Investing Cash Flow | -264.30M | -35.30M | -97.60M | -46.30M | -19.80M |
| Financing Cash Flow | -123.90M | -37.20M | -72.80M | 26.50M | -27.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $3.60B | 2.96 | 25.95% | 1.47% | ― | ― | |
70 Outperform | $3.11B | 11.08 | 17.30% | ― | 10.08% | 7.80% | |
69 Neutral | $1.23B | 9.34 | 21.89% | ― | 56.68% | 159.90% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | $1.02B | -11.53 | 10.36% | 0.99% | 18.88% | 26.40% | |
56 Neutral | $1.80B | 214.94 | -13.25% | 1.62% | -30.35% | ― | |
45 Neutral | $387.90M | -13.88 | -33.34% | ― | 3.07% | -157.38% |